Irbesartan (Compound)

Synonyms:irbesartan, 138402-11-6, Avapro, Aprovel, Karvea, SR-47436, BMS-186295, Irbesartan BMS, SR 47436, BMS 186295, Irbesartan Zentiva, Irbesartan D4, Sarbevel, Irbesartan teva, Irbesartan-d3, Irbesartan free base, NSC-758696, CHEMBL1513, 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one, 8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one, CHEBI:5959, DTXSID0023169, J0E2756Z7N, 138402-11-6 (free base), 2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro(4.4)non-1-en-4-one, 1,3-Diazaspiro(4.4)non-1-en-4-one, 2-butyl-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, NCGC00095122-01, 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, DTXCID903169, Irbetan, Irbesartan Krka, [3H]irbesartan, 3-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one, Irbesartan Winthrop, SMR000466306, Avapro (TN), CAS-138402-11-6, 1185120-76-6, 2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one, UNII-J0E2756Z7N, 3-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one, HSDB 8215, Irbesartan [USAN:USP:INN:BAN], Irbesartan ,(S), 2-butyl-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one, 3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one, Irbesartan- Bio-X, Irbesartan (Avapro), MFCD00864464, Spectrum_001751, IRBESARTAN [MI], IRBESARTAN [INN], IRBESARTAN [JAN], Spectrum2_001675, Spectrum3_000994, Spectrum4_001122, Spectrum5_001288, IRBESARTAN [USAN], IRBESARTAN [VANDF], IRBESARTAN [MART.], SCHEMBL4246, IRBESARTAN [USP-RS], IRBESARTAN [WHO-DD], BSPBio_002687, GTPL589, KBioGR_001603, KBioSS_002231, MLS000759408, MLS001424099, BIDD:GT0347, IRBESARTAN [EMA EPAR], SPECTRUM1504259, SPBio_001889, GTPL6908, Irbesartan (JP17/USP/INN), IRBESARTAN [EP IMPURITY], IRBESARTAN [ORANGE BOOK], KBio2_002231, KBio2_004799, KBio2_007367, KBio3_001907, IRBESARTAN [EP MONOGRAPH], IRBESARTAN [USP IMPURITY], BCPP000202, HMS1922J05, HMS2051L08, HMS2093E16, HMS2232F23, HMS3370B06, HMS3393L08, HMS3715L04, IRBESARTAN [USP MONOGRAPH], Pharmakon1600-01504259, AVALIDE COMPONENT IRBESARTAN, BCP02004, HY-B0202, Tox21_111433, AC-537, BDBM50042235, CCG-39091, COAPROVEL COMPONENT IRBESARTAN, NSC758696, STK645362, AKOS005576396, AKOS015895353, IFIRMACOMBI COMPONENT IRBESARTAN, IRBESARTAN COMPONENT OF AVALIDE, Irbesartan, >=98% (HPLC), powder, Tox21_111433_1, AB07472, AM90289, BCP9000792, CCG-101012, DB01029, KS-1151, NC00262, NSC 758696, 2-Butyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one, IRBESARTAN COMPONENT OF COAPROVEL, IRBESARTAN COMPONENT OF KARVEZIDE, NCGC00095122-02, NCGC00095122-03, NCGC00095122-04, NCGC00095122-05, NCGC00095122-14, 2-BUTYL-3-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1,3-DIAZASPIRO[4.4]NON-1-EN-4-ONE, BI164582, IRBESARTAN COMPONENT OF IFIRMACOMBI, SBI-0206769.P001, FT-0601598, FT-0670413, I0859, S1507, SR-47436;BMS-186295, C07469, D00523, AB00639954-06, AB00639954_07, AB00639954_08, A807387, EN300-37158602, L000319, Q947266, SR-05000001997, Q-201249, SR-05000001997-1, BRD-K60038276-001-02-5, BRD-K60038276-001-03-3, IBERSARTAN/HYDROCHLOROTHIAZIDE COMPONENT IBERSARTAN, Irbesartan, European Pharmacopoeia (EP) Reference Standard, IBERSARTAN/HYDROCHLOROTHIAZIDE TEVA COMPONENT IBERSARTAN, Irbesartan, United States Pharmacopeia (USP) Reference Standard, IBERSARTAN COMPONENT OF IBERSARTAN/HYDROCHLOROTHIAZIDE TEVA, IBERSARTAN COMPONENT OF IBERSARTAN/HYDROCHLOROTHIAZIDE ZENTIVA, IBERSARTAN/HYDROCHLOROTHIAZIDE ZENTIVA COMPONENT IBERSARTAN, Irbesartan, Pharmaceutical Secondary Standard; Certified Reference Material, 2-(n-butyl)-3-[[2'-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one, 2-Butyl-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[4.4]non-1-en-4-one, 2-butyl-3-{[2''-(1H-tetrazol-5-yl)[1,1''-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-{[2''-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one, 3-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)-methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one, 8-butyl-7-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one

Id:3749

Description:nan